Neelakantan and colleagues (Biochem Pharmacol, 2017) then took the pharmacological step, reporting that selective, membrane-permeable small-molecule NNMT inhibitors reversed high-fat-diet-induced obesity in mice this is the study most directly relevant to the 5-Amino-1MQ class, because it moves from the target matters to a drug against the target does something in a live animal. And again, it is a mouse study
I use Pascoe (1500 micrograms) now, and did initially use Rotexmedica
Early research is mostly preclinical, so it should not be treated as a proven anti-aging or fat-loss treatment
Keep product in cool, dark place
There's no universal 'best' here, just the 'best for your specific inquiry.' We encourage researchers to meticulously evaluate their project's unique requirements, consult with our expert team, and carefully consider the pharmacokinetic implications of each route
I hope things are well with you